PROTEINURIA IN TYPE 2 DIABETIC PATIENTS WITH RENAL IMPAIRMENT: THE CHANGING FACE OF DIABETIC NEPHROPATHY

被引：0
|
作者：
Packham, D. [1 ]
Ivory, S. [2 ]
Reutens, A. [2 ]
Wolfe, R. [2 ]
Rohde, R. [3 ]
Heerspink, H. [4 ]
Dwyer, J. [5 ]
Atkins, R. [2 ]
Lewis, J. [5 ]
机构：
[1] Monash Univ, Melbourne Renal Res Grp Pty Ltd, Melbourne, Vic 3004, Australia
[2] Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic 3004, Australia
[3] Rush Presbyterian St Lukes Med Ctr, Dept Med, Chicago, IL 60612 USA
[4] Univ Med Ctr Groningen, Groningen, Netherlands
[5] Vanderbilt Univ, Med Ctr, Dept Nephrol & Hypertens, Nashville, TN USA
来源：
NEPHROLOGY | 2010年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
021
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [1] Proteinuria in Type 2 Diabetic Patients with Renal Impairment: The Changing Face of Diabetic Nephropathy
    Packham, David K.
    Ivory, Sara E.
    Reutens, Anne T.
    Wolfe, Rory
    Rohde, Richard
    Heerspink, Hiddo Lambers
    Dwyer, Jamie P.
    Atkins, Robert C.
    Lewis, Julia
    [J]. NEPHRON CLINICAL PRACTICE, 2011, 118 (04): : C331 - C338
  • [2] Influence of rosiglitazone on proteinuria and renal haemodynamic in type 2 diabetic patients with overt diabetic nephropathy
    Pistrosch, F.
    Herbrig, K.
    Passauer, J.
    Kindel, B.
    Gross, P.
    Bornstein, S. R.
    [J]. DIABETOLOGIA, 2010, 53
  • [3] Proteinuria in diabetic patients - Is it always diabetic nephropathy?
    Bergner, R
    Lenz, T
    Henricha, DM
    Hoffmann, M
    Uppenkamp, M
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2006, 29 (01): : 48 - 53
  • [4] COULD PROTEINURIA PREDICT THE RENAL PROGNOSES OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND DIABETIC NEPHROPATHY?
    Wang, J. L.
    Sun, Y.
    Wang, Y.
    Wu, Y.
    Liu, F.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2022, 18 (01) : 29 - 34
  • [5] Effect of Thiazolidinedione Treatment on Proteinuria and Renal Hemodynamic in Type 2 Diabetic Patients with Overt Nephropathy
    Pistrosch, F.
    Passauer, J.
    Herbrig, K.
    Schwanebeck, U.
    Gross, P.
    Bornstein, S. R.
    [J]. HORMONE AND METABOLIC RESEARCH, 2012, 44 (12) : 914 - 918
  • [6] SIGNIFICANT INCREASE IN THE RENAL RESISTIVE INDEX IN PATIENTS WITH TYPE 2 DIABETIC NEPHROPATHY WITH OVERT PROTEINURIA
    Ogawa, Ayu
    Sugiyama, Hitoshi
    Kitagawa, Masashi
    Morinaga, Hiroshi
    Inoue, Tatsuyuki
    Takiue, Keiichi
    Kikumoto, Yoko
    Uchida, Haruhito Adam
    Kitamura, Shinji
    Maeshima, Yohei
    Tsuchiyama, Yoshinori
    Makino, Hirofumi
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 175 - 175
  • [7] Proteinuria reduction with probucol and telmisartan in patients with type 2 diabetic nephropathy
    Zhu, H.
    Chen, X.
    Cai, G.
    Zheng, Y.
    Liu, M.
    Liu, W.
    Wang, Y.
    Li, W.
    Wu, H.
    Zhang, J.
    Lun, L.
    Li, J.
    Zhou, C.
    [J]. DIABETOLOGIA, 2013, 56 : S46 - S46
  • [8] Establishment and Validation of a Nomogram Model for Prediction of Diabetic Nephropathy in Type 2 Diabetic Patients with Proteinuria
    Zhou, Dong-Mei
    Wei, Jing
    Zhang, Ting-Ting
    Shen, Feng-Jie
    Yang, Jin-Kui
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 1101 - 1110
  • [9] Effect of pioglitazone on decreasing of proteinuria in type 2 diabetic patients with nephropathy
    Pourshabanan, Pejman
    Momeni, Ali
    Mahmoudnia, Leila
    Kheiri, Soleiman
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 132 - 136
  • [10] Diabetic nephropathy: Renal structural studies in type 1 and type 2 diabetic patients
    Dalla Vestra, M
    Fioretto, P
    [J]. METABOLIC SYNDROME: DIABETES, OBESITY, HYPERLIPIDEMIA AND HYPERTENSION, 2003, 1253 : 163 - 169
12345